Niceritrol

CAS No. 5868-05-3

Niceritrol( Bufor | Cardiolipol | Perycit )

Catalog No. M27179 CAS No. 5868-05-3

Niceritrol is a niacin ester that reduces cholesterol and triglycerides in total plasma and in the VLD and LD lipoprotein fractions.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 145 In Stock
2MG 69 In Stock
5MG 100 In Stock
10MG 142 In Stock
25MG 255 In Stock
50MG 383 In Stock
100MG 566 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Niceritrol
  • Note
    Research use only, not for human use.
  • Brief Description
    Niceritrol is a niacin ester that reduces cholesterol and triglycerides in total plasma and in the VLD and LD lipoprotein fractions.
  • Description
    Niceritrol is a niacin ester that reduces cholesterol and triglycerides in total plasma and in the VLD and LD lipoprotein fractions.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Bufor | Cardiolipol | Perycit
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Cathepsin L| P. falciparum
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5868-05-3
  • Formula Weight
    556.531
  • Molecular Formula
    C29H24N4O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)c1cccnc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shah PP, et al. Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L. Mol Pharmacol. 2008 Jul;74(1):34-41.
molnova catalog
related products
  • Schisantherin B

    Schisantherin B shows good effect in lowering the serum glutamic-pyruvic transaminase level of the patients suffering from chronic virus hepatitis.

  • D-Glucose 6-phosphat...

    In cells D-glucose 6-phosphate (G6P) is generated when glucose is phosphorylated by hexokinase or glucokinase or by the conversion of glucose-1-phosphate by phosphoglucomutase during glycogenolysis. G6P lies at the beginning of both glycolysis and the pentose phosphate pathways. It also can be stored as glycogen when blood glucose levels are high.

  • Merafloxacin

    Merafloxacin is a fluoroquinolone antibacterial, which was also identified as a 1 PRF inhibitor of SARS-CoV-2.